Dhiraj Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dhiraj Kumar has a total of 148 co-authors. Here are the top co-authors by number of shared publications:
- Isha Mutreja
IMpact Biomaterials Lab, Division of Restorative Science, Minnesota Dental Research Center for Biomaterials and Biomechanics (MDRCBB), School of Dentistry, University of Minnesota, Minneapolis, MN 55455, USA
19 shared publications - Robert S. Jones
Department of Developmental & Surgical Sciences, University of Minnesota, Minneapolis, MN 55455, USA
12 shared publications Isha Mutreja
Impact Biomaterials Lab, Division of Restorative Science Minnesota Dental Research Center for Biomaterials and Biomechanics (MDRCBB), School of Dentistry University of Minnesota Minneapolis Minnesota USA
9 shared publications- Ajeet Kaushik
Florida Polytechnic University
6 shared publications - Conrado Aparicio
Bioinspired Oral Biomaterials and Interfaces, Department Ciencia e Ingenieria de Materiales, Escola Enginyeria Barcelona Est, Universitat Politècnica de Catalunya, Av. Eduard Maristany 16, 08019 Barcelona, Spain
6 shared publications Chiara Lowe
MARS Bioimaging Limited
4 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 17 (10) , 490
Modulating the Physicochemical Properties of Mesoporous Strontium Silicate Nanostructures Using a Design-of-Experiments Approach
Mesoporous silicate nanoparticles are known for their pore size, pore volume, high surface area, and tunable surface properties and, as a result, have found application in medicine, healthcare, advanced materials, and devices. Furthermore, tailoring the silicate domain with certain metals has advanced the tissue engineering properties by moderating the cellular function at the molecular level for therapeutic response. However, limited efforts have been made to explore systemic synthesis protocols that could change structure or shape of mesoporous metal silicate nanostructures as the change in shape has inherent potential to tailor biological response. Here, we have focused on using Design of Experiments (DoE) to optimize reaction conditions for the synthesis of mesoporous strontium silicate nanostructures (MPSrSiO2 NSs) (nanoparticles—NPs and nanorods—NRs) with different physicochemical properties. The conditions allowed a change in shape from NPs to NRs by tailoring the concentration of liquid ammonia (liq. NH3, NH4OH, 82.7 mM to 248.2 mM) during the pre-synthesis incubation state. The MPSrSiO2 NPs had a significantly higher zeta potential compared to NPs (p = 0.0061). Also, NPs possessed significantly higher surface area (p = 0.0306), pore diameter (p = 0.0003), and pore volume (p = 0.0004) than NRs. In addition, the optimized reaction conditions allowed modulation of the physicochemical properties such as surface area, surface charge, amount of metal, pore diameter, pore volume, tailored degradation profile and release profile of loaded drug (gentamicin). Finally, the protocol has the advantage of allowing incorporation of other metals such as cerium, rhodium, and ruthenium independently and/or in combination.
- 29 September 2026
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 17 (10) , 490
Open AccessModulating the Physicochemical Properties of Mesoporous Strontium Silicate Nanostructures Using a Design-of-Experiments Approach
Mesoporous silicate nanoparticles are known for their pore size, pore volume, high surface area, and tunable surface properties and, as a result, have found application in medicine, healthcare, advanced materials, and devices. Furthermore, tailoring the silicate domain with certain metals has advanced the tissue engineering properties by moderating the cellular function at the molecular level for therapeutic response. However, limited efforts have been made to explore systemic synthesis protocols that could change structure or shape of mesoporous metal silicate nanostructures as the change in shape has inherent potential to tailor biological response. Here, we have focused on using Design of Experiments (DoE) to optimize reaction conditions for the synthesis of mesoporous strontium silicate nanostructures (MPSrSiO2 NSs) (nanoparticles—NPs and nanorods—NRs) with different physicochemical properties. The conditions allowed a change in shape from NPs to NRs by tailoring the concentration of liquid ammonia (liq. NH3, NH4OH, 82.7 mM to 248.2 mM) during the pre-synthesis incubation state. The MPSrSiO2 NPs had a significantly higher zeta potential compared to NPs (p = 0.0061). Also, NPs possessed significantly higher surface area (p = 0.0306), pore diameter (p = 0.0003), and pore volume (p = 0.0004) than NRs. In addition, the optimized reaction conditions allowed modulation of the physicochemical properties such as surface area, surface charge, amount of metal, pore diameter, pore volume, tailored degradation profile and release profile of loaded drug (gentamicin). Finally, the protocol has the advantage of allowing incorporation of other metals such as cerium, rhodium, and ruthenium independently and/or in combination.
- Open Access
- 3 September 2026
- Published by MDPI AG in Preprints.org
Modulating Physicochemical Features of Mesoporous Strontium Silicate Nanostructures: A Design of Experiments Approach
Mesoporous silicate nanoparticles are known for pore size, pore volume, high surface area, and tunable surface properties and as a result, have found application in medicine, healthcare, advanced materials, and devices. Furthermore, tailoring the silicate domain with certain metals has advanced the tissue engineering properties by moderating the cellular function at the molecular level for therapeutic response. However, scarce efforts have been made to explore systemic methods that could change the structure and shape of these particles and their effects on biological properties. Here, we have focused on, using Design of Experiments (DoE), optimizing reaction conditions for the synthesis of mesoporous strontium silicate nanostructures (NS) (nanoparticles – NPs and nanorods – NRs) with different physico-chemical properties. The conditions allowed change in shape from NPs to NRs by tailoring the concentration of liquid ammonia (NH4OH, 82.7 mM to 248.2 mM) during the pre-synthesis incubation state. In addition, the optimized reaction conditions allowed modulating the physico-chemical properties such as surface area, surface charge, amount of metal, pore diameter, pore volume, tailored degradation profile and release profile of the loaded drug (gentamicin). Finally, the protocol has the advantage of allowing incorporation of other metals such as cerium, rhodium, and ruthenium independently and/or in combination.
- 3 September 2026
- Published by MDPI AG in Preprints.org
Open AccessModulating Physicochemical Features of Mesoporous Strontium Silicate Nanostructures: A Design of Experiments Approach
Mesoporous silicate nanoparticles are known for pore size, pore volume, high surface area, and tunable surface properties and as a result, have found application in medicine, healthcare, advanced materials, and devices. Furthermore, tailoring the silicate domain with certain metals has advanced the tissue engineering properties by moderating the cellular function at the molecular level for therapeutic response. However, scarce efforts have been made to explore systemic methods that could change the structure and shape of these particles and their effects on biological properties. Here, we have focused on, using Design of Experiments (DoE), optimizing reaction conditions for the synthesis of mesoporous strontium silicate nanostructures (NS) (nanoparticles – NPs and nanorods – NRs) with different physico-chemical properties. The conditions allowed change in shape from NPs to NRs by tailoring the concentration of liquid ammonia (NH4OH, 82.7 mM to 248.2 mM) during the pre-synthesis incubation state. In addition, the optimized reaction conditions allowed modulating the physico-chemical properties such as surface area, surface charge, amount of metal, pore diameter, pore volume, tailored degradation profile and release profile of the loaded drug (gentamicin). Finally, the protocol has the advantage of allowing incorporation of other metals such as cerium, rhodium, and ruthenium independently and/or in combination.
- Open Access
- 7 August 2026
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 75 (8) , 002192
Ex vivo inhibition of enamel phosphate uptake in Rothia dentocariosa
Introduction. Oral bacteria, such as Rothia dentocariosa ( Rd ), can modulate external aqueous phase orthophosphate (P i ) concentrations via P i internalization and accumulate high amounts of P i in the form of polyphosphate (polyP). Hypothesis/Gap Statement. This study investigates whether the carbohydrate metabolism of Rd that generates acid and solubilizes P i , derived from phosphorus-32 ( 32 P)-labelled tooth enamel, can be internalized and incorporated into intracellular polyP. The study investigated the hypothesis that the internalization of tooth-derived P i and polyP synthesis could be attenuated. Aim. A radionuclide 32 P-labelled remineralized model examined the influence of gallein, an inhibitor of polyP kinases, on the ingestion of tooth-derived P i and on the bacterium’s cultivability. Methodology. Radionuclide 32 P-labelled remineralized bovine enamel ( n =6) was exposed to Rd (ATCC 17931) incubated in brain heart infusion (BHI) broth containing glucose. Attenuated total reflectance Fourier transform infrared (FTIR) spectroscopy and cross-polarization optical coherence tomography assessed the surface and subsurface characteristics of the remineralized and demineralized enamel surface. Liquid scintillation traced the 32 P release from the tooth to the intracellular polyP in gallein pos/neg samples. Cell-media, supernatant, cell resuspension, and extracted polyP, from Rd exposed to the radioisotope-labelled remineralized enamel, were analysed for 32 P activity at 10 and 22 h time points. Results. FTIR determined that 32 P was incorporated in dental enamel lesions and was released after exposure to an acidic buffer (pH=4.5) or Rd . After 24 h of exposure, gallein pos reduced Rd ’s planktonic growth and increased pH by 7.45% and 7.19%, respectively, compared to gallein neg . Gallein inhibited the cultivability of planktonic Rd on BHI agar plates with a 13- to 60-fold reduction of c.f.u. ml −1 (25 µM–13.03×, 50 µM–19.58× and 100 µM–60.57×) compared to gallein neg samples. Isotope labelling demonstrated that Rd used P i derived directly from the tooth for the benefit of the bacterium’s fitness through the formation of polyP. Conclusion. Rd used the P i derived directly from the tooth for the benefit of the bacterium’s fitness. Gallein attenuated polyP accumulation, reduced bacterial cultivability and may be a potential therapy option in the prevention and treatment of primary and secondary caries.
- 7 August 2026
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 75 (8) , 002192
Open AccessEx vivo inhibition of enamel phosphate uptake in Rothia dentocariosa
Introduction. Oral bacteria, such as Rothia dentocariosa ( Rd ), can modulate external aqueous phase orthophosphate (P i ) concentrations via P i internalization and accumulate high amounts of P i in the form of polyphosphate (polyP). Hypothesis/Gap Statement. This study investigates whether the carbohydrate metabolism of Rd that generates acid and solubilizes P i , derived from phosphorus-32 ( 32 P)-labelled tooth enamel, can be internalized and incorporated into intracellular polyP. The study investigated the hypothesis that the internalization of tooth-derived P i and polyP synthesis could be attenuated. Aim. A radionuclide 32 P-labelled remineralized model examined the influence of gallein, an inhibitor of polyP kinases, on the ingestion of tooth-derived P i and on the bacterium’s cultivability. Methodology. Radionuclide 32 P-labelled remineralized bovine enamel ( n =6) was exposed to Rd (ATCC 17931) incubated in brain heart infusion (BHI) broth containing glucose. Attenuated total reflectance Fourier transform infrared (FTIR) spectroscopy and cross-polarization optical coherence tomography assessed the surface and subsurface characteristics of the remineralized and demineralized enamel surface. Liquid scintillation traced the 32 P release from the tooth to the intracellular polyP in gallein pos/neg samples. Cell-media, supernatant, cell resuspension, and extracted polyP, from Rd exposed to the radioisotope-labelled remineralized enamel, were analysed for 32 P activity at 10 and 22 h time points. Results. FTIR determined that 32 P was incorporated in dental enamel lesions and was released after exposure to an acidic buffer (pH=4.5) or Rd . After 24 h of exposure, gallein pos reduced Rd ’s planktonic growth and increased pH by 7.45% and 7.19%, respectively, compared to gallein neg . Gallein inhibited the cultivability of planktonic Rd on BHI agar plates with a 13- to 60-fold reduction of c.f.u. ml −1 (25 µM–13.03×, 50 µM–19.58× and 100 µM–60.57×) compared to gallein neg samples. Isotope labelling demonstrated that Rd used P i derived directly from the tooth for the benefit of the bacterium’s fitness through the formation of polyP. Conclusion. Rd used the P i derived directly from the tooth for the benefit of the bacterium’s fitness. Gallein attenuated polyP accumulation, reduced bacterial cultivability and may be a potential therapy option in the prevention and treatment of primary and secondary caries.
- Open Access
Characterizing Multifunctional Mesoporous Cerium Silicate Nanoparticles for Potential Use in Bioactive Dental Materials: A Proof-of-Concept Study
(1) Background: Cerium silicate (CeSi) nanoparticles (NPs) have potential as a restorative filler particle with multifunctional properties to improve longevity. To increase the biological activity, these nanoparticles can be fabricated with ultrasmall pores (mesoporous) (MPCeSi-NP) that can be loaded with a polyphosphate inhibitor, such as gallein. (2) Methods: MPCeSi-NPs were custom-synthesized with a microemulsion method, using cetyltrimethylammonium bromide (CTAB) as a template for self-assembly. Biocompatibility with oral keratinocytes/fibroblasts was tested, with the addition of examining the biomineralization potential with human bone-marrow-derived mesenchymal stromal cells (BM-MSCs). MPCeSi-NP, loaded with gallein, was tested against Rothia dentocariosa (Rd). MPCeSi-NP was added to a resin matrix of triethylene glycol dimethacrylate (TEGDMA) and Bisphenol A-glycidyl methacrylate (BisGMA) with subsequent mechanical properties evaluation. (3) Results: MPCeSi-NPs had high biocompatibility with oral keratinocytes and fibroblasts, especially at concentrations below 300 µg/mL. MPCeSi-NPs induced the biomineralization of BM-MSCs. Higher cerium levels increased mineralization. MPCeSi-NP had weak antimicrobial activity against Rd. At 1% wt, MPCeSi-NPs did not reduce the polymerization potential and mechanical properties of a TEGDMA:BisGMA polymer material, with controlled release of gallein in a simulated degradation model. (4) Conclusions: MPCeSi-NPs are highly biocompatible and bioinductive and have the potential to improve the biological response of current restorative materials.
Open AccessCharacterizing Multifunctional Mesoporous Cerium Silicate Nanoparticles for Potential Use in Bioactive Dental Materials: A Proof-of-Concept Study
(1) Background: Cerium silicate (CeSi) nanoparticles (NPs) have potential as a restorative filler particle with multifunctional properties to improve longevity. To increase the biological activity, these nanoparticles can be fabricated with ultrasmall pores (mesoporous) (MPCeSi-NP) that can be loaded with a polyphosphate inhibitor, such as gallein. (2) Methods: MPCeSi-NPs were custom-synthesized with a microemulsion method, using cetyltrimethylammonium bromide (CTAB) as a template for self-assembly. Biocompatibility with oral keratinocytes/fibroblasts was tested, with the addition of examining the biomineralization potential with human bone-marrow-derived mesenchymal stromal cells (BM-MSCs). MPCeSi-NP, loaded with gallein, was tested against Rothia dentocariosa (Rd). MPCeSi-NP was added to a resin matrix of triethylene glycol dimethacrylate (TEGDMA) and Bisphenol A-glycidyl methacrylate (BisGMA) with subsequent mechanical properties evaluation. (3) Results: MPCeSi-NPs had high biocompatibility with oral keratinocytes and fibroblasts, especially at concentrations below 300 µg/mL. MPCeSi-NPs induced the biomineralization of BM-MSCs. Higher cerium levels increased mineralization. MPCeSi-NP had weak antimicrobial activity against Rd. At 1% wt, MPCeSi-NPs did not reduce the polymerization potential and mechanical properties of a TEGDMA:BisGMA polymer material, with controlled release of gallein in a simulated degradation model. (4) Conclusions: MPCeSi-NPs are highly biocompatible and bioinductive and have the potential to improve the biological response of current restorative materials.
- Open Access
- 10 December 2025
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 11 (6) , e70259
Tissue Biocompatibility and Antimicrobial Properties of Sympathomimetic Nasal Solutions for Potential Use in Dental Pulpal Management
Objectives: Sympathomimetic nasal solutions (SNS), containing oxymetazoline or phenylephrine, may be used directly onto dental pulp tissue and initiate hemostasis via activation of alpha‐receptors that innervate arteriole smooth muscles. The aim of this study was to assess these SNS's biocompatibility with human dental pulp stem cells (hDPSCs) and ability to kill a deep caries‐associated pathogen, Rothia dentocariosa . Materials and Methods: A Kirby‐Bauer disk diffusion susceptibility test assessed SNS zones of inhibition (ZOI) toward R. dentocariosa growth on agar plates. Over‐the‐counter (OTC) SNS containing 0.025% and 0.05% oxymetazoline (NS‐OXY‐kids, NS‐OXY‐original) and 1% phenylephrine (NS‐PHE) were tested along with ingredients found in these nasal solutions: 0.025%, 0.05% oxymetazoline; 0.0125%, 0.025% benzalkonium chloride; and 0.2%, 1% phenylephrine (PHE). A second antimicrobial broth inhibition assay examined effects on R. dentocariosa planktonic growth. A 24‐h recovery biocompatibility assay with resazurin (alamarBlue) was performed on hDPSC that were exposed to pure respective compound solutions, NS‐OXY‐kids, NS‐PHE, and 1% PHE for 10 min. Results: NS‐OXY‐kids, NS‐OXY‐original, NS‐PHE, and 0.025% BKC were bactericidal toward R. dentocariosa with an average ZOI of (16.33 ± 2.22 [average ± SD] mm). NS‐PHE had a small but statistically significant difference (17.83 ± 3.189 mm) between NS‐OXY‐kids (14.67 ± 1.033 mm); 0.0125% BKC had a smaller ( p < 0.05) ZOI of 10.5 ± 0.837 mm. Solutions containing solely OXY (0.025%, 0.05%) and PHE (0.2%, 1%) demonstrated no bactericidal activity but had a slight bacteriostatic inhibition in the broth inhibition assay. The commercial OTC formulations of NS‐PHE and NS‐OXY‐kids needed to be diluted 1:10 to have near 50% metabolic activity of hDPSCs normalized to untreated control cells. Conclusions: NS‐PHE and NS‐OXY (both original and kids) had antimicrobial activity toward R. dentocariosa and comparable biocompatibility with hDPSCs. SNS may have both hemostatic and antimicrobial properties if used as pulpal medicaments.
- 10 December 2025
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 11 (6) , e70259
Open AccessTissue Biocompatibility and Antimicrobial Properties of Sympathomimetic Nasal Solutions for Potential Use in Dental Pulpal Management
Objectives: Sympathomimetic nasal solutions (SNS), containing oxymetazoline or phenylephrine, may be used directly onto dental pulp tissue and initiate hemostasis via activation of alpha‐receptors that innervate arteriole smooth muscles. The aim of this study was to assess these SNS's biocompatibility with human dental pulp stem cells (hDPSCs) and ability to kill a deep caries‐associated pathogen, Rothia dentocariosa . Materials and Methods: A Kirby‐Bauer disk diffusion susceptibility test assessed SNS zones of inhibition (ZOI) toward R. dentocariosa growth on agar plates. Over‐the‐counter (OTC) SNS containing 0.025% and 0.05% oxymetazoline (NS‐OXY‐kids, NS‐OXY‐original) and 1% phenylephrine (NS‐PHE) were tested along with ingredients found in these nasal solutions: 0.025%, 0.05% oxymetazoline; 0.0125%, 0.025% benzalkonium chloride; and 0.2%, 1% phenylephrine (PHE). A second antimicrobial broth inhibition assay examined effects on R. dentocariosa planktonic growth. A 24‐h recovery biocompatibility assay with resazurin (alamarBlue) was performed on hDPSC that were exposed to pure respective compound solutions, NS‐OXY‐kids, NS‐PHE, and 1% PHE for 10 min. Results: NS‐OXY‐kids, NS‐OXY‐original, NS‐PHE, and 0.025% BKC were bactericidal toward R. dentocariosa with an average ZOI of (16.33 ± 2.22 [average ± SD] mm). NS‐PHE had a small but statistically significant difference (17.83 ± 3.189 mm) between NS‐OXY‐kids (14.67 ± 1.033 mm); 0.0125% BKC had a smaller ( p < 0.05) ZOI of 10.5 ± 0.837 mm. Solutions containing solely OXY (0.025%, 0.05%) and PHE (0.2%, 1%) demonstrated no bactericidal activity but had a slight bacteriostatic inhibition in the broth inhibition assay. The commercial OTC formulations of NS‐PHE and NS‐OXY‐kids needed to be diluted 1:10 to have near 50% metabolic activity of hDPSCs normalized to untreated control cells. Conclusions: NS‐PHE and NS‐OXY (both original and kids) had antimicrobial activity toward R. dentocariosa and comparable biocompatibility with hDPSCs. SNS may have both hemostatic and antimicrobial properties if used as pulpal medicaments.
- Open Access
- 27 March 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1-11
The use of oxymetazoline-based nasal solutions to remove bacteria-blood debris and eradicate Rothia dentocariosa: an artificial cavity model study
This study evaluated the antibacterial properties of a potential pulpal medicament, a nasal solution with oxymetazoline (NS-OXY, 0.05%), against a dentinal caries pathogen. Using a disc diffusion susceptibility test (n = 6), Rothia dentocariosa was grown on brain–heart infusion (BHI) agar plates and exposed to OXY (0.05%), benzalkonium chloride (BKC-0.025%), OXY-NS (with OXY-0.05% and BKC), ferric sulfate (20%; ViscoStat), and distilled water (DI). This was followed by exposure of an artificial dental caries model with sheep blood to simulate the clinical pulpotomy procedure. An antibacterial broth inhibition test was conducted by adding the test samples in BHI broth at 37 ± 0.5 °C in an aerobic chamber. In the disc diffusion test, NS-OXY and BKC had the largest zone of inhibition (ZOI) measuring 14.42 mm (± 1.62) and 18.92 mm (± 4.14) respectively, indicating antibacterial activity. Ferric sulfate demonstrated a smaller ZOI, while OXY alone had no ZOI. The antibacterial broth test showed antibacterial effects with stable OD and pH levels for test samples containing BKC (0.025%) and diluted NS-OXY (0.01%) for up to 20 h. DI- and OXY-treated samples showed an increase in OD, indicating an increase in bacterial count and a concurrent drop in pH. BKC treatment statistically (P < 0.05) reduced polyP extracts, which may contribute to blood clot formation. NS-OXY demonstrated antibacterial properties, likely due to the addition of BKC to Rothia dentocariosa. NS-OXY showed concentration dependent biocompatibility with dental pulp stem cells while FS was cytotoxic at the same dilution. These antimicrobial properties, together with OXY’s hemostatic effects, suggest the potential off-label use of NS-OXY during a pulpotomy procedure in primary and permanent teeth. This study provides support for potential future clinical trials of repurposing FDA-approved drugs consisting of oxymetazoline and benzalkonium chloride for dental and other similar applications. An over-the-counter nasal solution containing oxymetazoline has the potential to be used off-label to manage surgical bleeding from dental pulp exposures and provide antimicrobial properties against Rothia dentocariosa, a model gram-positive bacteria associated with deep dentinal caries.
- 27 March 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1-11
Open AccessThe use of oxymetazoline-based nasal solutions to remove bacteria-blood debris and eradicate Rothia dentocariosa: an artificial cavity model study
This study evaluated the antibacterial properties of a potential pulpal medicament, a nasal solution with oxymetazoline (NS-OXY, 0.05%), against a dentinal caries pathogen. Using a disc diffusion susceptibility test (n = 6), Rothia dentocariosa was grown on brain–heart infusion (BHI) agar plates and exposed to OXY (0.05%), benzalkonium chloride (BKC-0.025%), OXY-NS (with OXY-0.05% and BKC), ferric sulfate (20%; ViscoStat), and distilled water (DI). This was followed by exposure of an artificial dental caries model with sheep blood to simulate the clinical pulpotomy procedure. An antibacterial broth inhibition test was conducted by adding the test samples in BHI broth at 37 ± 0.5 °C in an aerobic chamber. In the disc diffusion test, NS-OXY and BKC had the largest zone of inhibition (ZOI) measuring 14.42 mm (± 1.62) and 18.92 mm (± 4.14) respectively, indicating antibacterial activity. Ferric sulfate demonstrated a smaller ZOI, while OXY alone had no ZOI. The antibacterial broth test showed antibacterial effects with stable OD and pH levels for test samples containing BKC (0.025%) and diluted NS-OXY (0.01%) for up to 20 h. DI- and OXY-treated samples showed an increase in OD, indicating an increase in bacterial count and a concurrent drop in pH. BKC treatment statistically (P < 0.05) reduced polyP extracts, which may contribute to blood clot formation. NS-OXY demonstrated antibacterial properties, likely due to the addition of BKC to Rothia dentocariosa. NS-OXY showed concentration dependent biocompatibility with dental pulp stem cells while FS was cytotoxic at the same dilution. These antimicrobial properties, together with OXY’s hemostatic effects, suggest the potential off-label use of NS-OXY during a pulpotomy procedure in primary and permanent teeth. This study provides support for potential future clinical trials of repurposing FDA-approved drugs consisting of oxymetazoline and benzalkonium chloride for dental and other similar applications. An over-the-counter nasal solution containing oxymetazoline has the potential to be used off-label to manage surgical bleeding from dental pulp exposures and provide antimicrobial properties against Rothia dentocariosa, a model gram-positive bacteria associated with deep dentinal caries.
- Open Access
- 31 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (3) , 1242
An Oxymetazoline-Based Nasal Solution Removes Bacteria–Blood Debris on Dental Surfaces and Has Antimicrobial Activity Toward Streptococcus mutans
Background: An over-the-counter vasoconstrictive nasal solution with oxymetazoline (NS-OXY, 0.05%) has the potential to be used as a dental pulpal hemostatic medicament. A molecular engineering approach examined NS-OXY and its molecular constituent’s antimicrobial and blood biomass removal efficacy. Methods: An ex vivo cavity model was developed where standardized prepared teeth were exposed overnight to a model dentinal caries pathogen, S. mutans, and then exposed to sheep’s blood for 10 min, which simulated a pulpal exposure. Cavity preparations were rinsed with OXY (0.05%), benzalkonium chloride (BKC-0.025%), NS-OXY (with OXY-0.05% and BKC), ferric sulfate (20%;ViscoStat, FS), and distilled water (DI). For examining the bactericidal effect of NS-OXY, a disk diffusion antimicrobial assay was used where S. mutans was grown (20 h) on brain heart infusion (BHI) w/0.5% glucose agar plates and exposed to the treatment groups. Results: NS-OXY-treated samples had a lower residual bacterial or blood biomass than FS (p = 0.003). The diffusion test showed that NS-OXY, BKC, and FS had zones of inhibition greater than 10 mm, with NS-OXY having higher activity against S. mutans than FS (p = 0.0002), but lower than BKC (p = 0.0082). Conclusions: NS-OXY may be considered as a dental hemostatic agent after traumatic and carious pulpal exposure owing to NS-OXY’s antimicrobial and vasoconstrictive properties.
- 31 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (3) , 1242
Open AccessAn Oxymetazoline-Based Nasal Solution Removes Bacteria–Blood Debris on Dental Surfaces and Has Antimicrobial Activity Toward Streptococcus mutans
Background: An over-the-counter vasoconstrictive nasal solution with oxymetazoline (NS-OXY, 0.05%) has the potential to be used as a dental pulpal hemostatic medicament. A molecular engineering approach examined NS-OXY and its molecular constituent’s antimicrobial and blood biomass removal efficacy. Methods: An ex vivo cavity model was developed where standardized prepared teeth were exposed overnight to a model dentinal caries pathogen, S. mutans, and then exposed to sheep’s blood for 10 min, which simulated a pulpal exposure. Cavity preparations were rinsed with OXY (0.05%), benzalkonium chloride (BKC-0.025%), NS-OXY (with OXY-0.05% and BKC), ferric sulfate (20%;ViscoStat, FS), and distilled water (DI). For examining the bactericidal effect of NS-OXY, a disk diffusion antimicrobial assay was used where S. mutans was grown (20 h) on brain heart infusion (BHI) w/0.5% glucose agar plates and exposed to the treatment groups. Results: NS-OXY-treated samples had a lower residual bacterial or blood biomass than FS (p = 0.003). The diffusion test showed that NS-OXY, BKC, and FS had zones of inhibition greater than 10 mm, with NS-OXY having higher activity against S. mutans than FS (p = 0.0002), but lower than BKC (p = 0.0082). Conclusions: NS-OXY may be considered as a dental hemostatic agent after traumatic and carious pulpal exposure owing to NS-OXY’s antimicrobial and vasoconstrictive properties.
- Open Access
- 28 November 2024
- Published by Microbiology Society in Microbiology
- Vol. 170 (11) , 001519
Fluoride and gallein regulate polyphosphate accumulation in dental caries-associated Lacticaseibacillus
Inorganic polyphosphates (polyPs) are energy-storing biopolymers synthesized by all three domains of life. PolyP accumulation has been well studied with respect to its role in stress response, but its role in dental disease has received less attention. Dental decay can be promoted by changes in pH as well as the chemical activity of ions such as phosphate in oral fluids at the enamel interface. Previous work has shown that the drawdown of phosphate from biofilm fluids can alter the saturation state of oral fluids to thermodynamically favour mineral dissolution. The members of the Lactobacillaceae are known to accumulate polyP and play a role in early-stage and late-stage dental caries. In this study, we examined the effects of potential metabolic inhibitors on polyP accumulation in Lacticaseibacillus rhamnosus. We observed that two inhibitors of the enzyme responsible for polyP synthesis, gallein and fluoride, inhibited polyP accumulation in a balanced medium. However, fluoride and gallein treatments amended with either glucose or lactate were found to enhance polyP accumulation. These results illustrate the potential complexity of polyP metabolism in the oral environment.
- 28 November 2024
- Published by Microbiology Society in Microbiology
- Vol. 170 (11) , 001519
Open AccessFluoride and gallein regulate polyphosphate accumulation in dental caries-associated Lacticaseibacillus
Inorganic polyphosphates (polyPs) are energy-storing biopolymers synthesized by all three domains of life. PolyP accumulation has been well studied with respect to its role in stress response, but its role in dental disease has received less attention. Dental decay can be promoted by changes in pH as well as the chemical activity of ions such as phosphate in oral fluids at the enamel interface. Previous work has shown that the drawdown of phosphate from biofilm fluids can alter the saturation state of oral fluids to thermodynamically favour mineral dissolution. The members of the Lactobacillaceae are known to accumulate polyP and play a role in early-stage and late-stage dental caries. In this study, we examined the effects of potential metabolic inhibitors on polyP accumulation in Lacticaseibacillus rhamnosus. We observed that two inhibitors of the enzyme responsible for polyP synthesis, gallein and fluoride, inhibited polyP accumulation in a balanced medium. However, fluoride and gallein treatments amended with either glucose or lactate were found to enhance polyP accumulation. These results illustrate the potential complexity of polyP metabolism in the oral environment.
- Open Access
- 19 June 2024
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 35 (1) , 1-11
Optimizing alkaline hydrothermal treatment for biomimetic smart metallic orthopedic and dental implants
Orthopedic and dental implant failure continues to be a significant concern due to localized bacterial infections. Previous studies have attempted to improve implant surfaces by modifying their texture and roughness or coating them with antibiotics to enhance antibacterial properties for implant longevity. However, these approaches have demonstrated limited effectiveness. In this study, we attempted to engineer the titanium (Ti) alloy surface biomimetically at the nanometer scale, inspired by the cicada wing nanostructure using alkaline hydrothermal treatment (AHT) to simultaneously confer antibacterial properties and support the adhesion and proliferation of mammalian cells. The two modified Ti surfaces were developed using a 4 h and 8 h AHT process in 1 N NaOH at 230 °C, followed by a 2-hour post-calcination at 600 °C. We found that the control plates showed a relatively smooth surface, while the treatment groups (4 h & 8 h AHT) displayed nanoflower structures containing randomly distributed nano-spikes. The results demonstrated a statistically significant decrease in the contact angle of the treatment groups, which increased wettability characteristics. The 8 h AHT group exhibited the highest wettability and significant increase in roughness 0.72 ± 0.08 µm (P < 0.05), leading to more osteoblast cell attachment, reduced cytotoxicity effects, and enhanced relative survivability. The alkaline phosphatase activity measured in all different groups indicated that the 8 h AHT group exhibited the highest activity, suggesting that the surface roughness and wettability of the treatment groups may have facilitated cell adhesion and attachment and subsequently increased secretion of extracellular matrix. Overall, the findings indicate that biomimetic nanotextured surfaces created by the AHT process have the potential to be translated as implant coatings to enhance bone regeneration and implant integration. Graphical Abstract
- 19 June 2024
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 35 (1) , 1-11
Open AccessOptimizing alkaline hydrothermal treatment for biomimetic smart metallic orthopedic and dental implants
Orthopedic and dental implant failure continues to be a significant concern due to localized bacterial infections. Previous studies have attempted to improve implant surfaces by modifying their texture and roughness or coating them with antibiotics to enhance antibacterial properties for implant longevity. However, these approaches have demonstrated limited effectiveness. In this study, we attempted to engineer the titanium (Ti) alloy surface biomimetically at the nanometer scale, inspired by the cicada wing nanostructure using alkaline hydrothermal treatment (AHT) to simultaneously confer antibacterial properties and support the adhesion and proliferation of mammalian cells. The two modified Ti surfaces were developed using a 4 h and 8 h AHT process in 1 N NaOH at 230 °C, followed by a 2-hour post-calcination at 600 °C. We found that the control plates showed a relatively smooth surface, while the treatment groups (4 h & 8 h AHT) displayed nanoflower structures containing randomly distributed nano-spikes. The results demonstrated a statistically significant decrease in the contact angle of the treatment groups, which increased wettability characteristics. The 8 h AHT group exhibited the highest wettability and significant increase in roughness 0.72 ± 0.08 µm (P < 0.05), leading to more osteoblast cell attachment, reduced cytotoxicity effects, and enhanced relative survivability. The alkaline phosphatase activity measured in all different groups indicated that the 8 h AHT group exhibited the highest activity, suggesting that the surface roughness and wettability of the treatment groups may have facilitated cell adhesion and attachment and subsequently increased secretion of extracellular matrix. Overall, the findings indicate that biomimetic nanotextured surfaces created by the AHT process have the potential to be translated as implant coatings to enhance bone regeneration and implant integration. Graphical Abstract